These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 1133736)
21. THE IMPORTANCE OF LIPID-SOLUBILITY FOR THE CENTRAL ACTION OF CHOLINOLYTIC DRUGS. HERZ A; TESCHEMACHER H; HOFSTETTER A; KURZ H Int J Neuropharmacol; 1965 Jul; 4():207-18. PubMed ID: 14343875 [No Abstract] [Full Text] [Related]
22. Comparative behavioral effects of anticholinergic agents in cats: psychomotor stimulation and aggression. Beleslin DB; Stefanović-Denić K; Samardzić R Pharmacol Biochem Behav; 1986 Mar; 24(3):581-6. PubMed ID: 3703893 [TBL] [Abstract][Full Text] [Related]
23. [Pharmacology of the bronchospasmolytic oxitropium bromide]. Bauer VR Arzneimittelforschung; 1985; 35(1A):435-40. PubMed ID: 4039183 [TBL] [Abstract][Full Text] [Related]
24. Quaternary forms of classical muscarinic antagonists distinguish subpopulations of muscarinic receptors: correlation with gallamine-defined subpopulations. Ellis J; Lenox RH Biochem Biophys Res Commun; 1985 Feb; 126(3):1242-50. PubMed ID: 3977914 [TBL] [Abstract][Full Text] [Related]
25. Efficacy evaluation of physostigmine and anticholinergic adjuncts as a pretreatment for nerve agent intoxication. von Bredow J; Corcoran K; Maitland G; Kaminskis A; Adams N; Wade J Fundam Appl Toxicol; 1991 Nov; 17(4):782-9. PubMed ID: 1778364 [TBL] [Abstract][Full Text] [Related]
26. [The M-receptor antagonism of a new cholinolytic compounds TBBB in comparison with hyocine bromide (HBB) and atropine]. Dai DZ; Lin J; Wang LY; Zhang DL; Huang J; Xing WF Yao Xue Xue Bao; 1986 Nov; 21(11):853-6. PubMed ID: 3591321 [No Abstract] [Full Text] [Related]
27. Microwave facilitation of methylatropine antagonism of central cholinomimetic drug effects. Quock RM; Fujimoto JM; Ishii TK; Lange DG Radiat Res; 1986 Mar; 105(3):328-40. PubMed ID: 3961098 [TBL] [Abstract][Full Text] [Related]
28. [Comparison of the effects of cholinergic and anticholinergic substances on the cerebral content of acetylcholine and on the motility of mice]. Frances H; Jacob J Psychopharmacologia; 1971; 21(4):338-52. PubMed ID: 5098932 [No Abstract] [Full Text] [Related]
29. Soft drugs. 12: Design, syntheses and evaluation of soft anticholinergics. Kumar GN; Hammer RH; Bodor NS Drug Des Discov; 1993; 10(1):11-21. PubMed ID: 8399991 [TBL] [Abstract][Full Text] [Related]
30. Anticholinergic drugs in airways obstruction. Anderson G Postgrad Med J; 1983; 59 Suppl 3():64-5. PubMed ID: 6227880 [TBL] [Abstract][Full Text] [Related]
34. Oxybutynin--a musculotropic antispasmodic drug with moderate anticholinergic action. Lish PM; Labudde JA; Peters EL; Robbins SI Arch Int Pharmacodyn Ther; 1965 Aug; 156(2):467-88. PubMed ID: 4380481 [No Abstract] [Full Text] [Related]
35. Morphine tolerance and physical dependence: influence of cholinergic agonists and antagonists. Bhargava HN; Way EL Eur J Pharmacol; 1976 Mar; 36(1):79-88. PubMed ID: 944135 [TBL] [Abstract][Full Text] [Related]
36. Anticholinergic drugs and the central control of thirst. STEIN L Science; 1963 Jan; 139(3549):46-8. PubMed ID: 13983691 [TBL] [Abstract][Full Text] [Related]
37. Rapid induction of supersensitivity to muscarinic antagonists-induced motor excitation by continuous stimulation of cholinergic receptors. Fernando JC; Hoskins B; Ho IK Life Sci; 1985 Sep; 37(9):883-92. PubMed ID: 4041002 [TBL] [Abstract][Full Text] [Related]